Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History HOWL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics HOWL

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Werewolf Therapeutics Inc

HOWL
Current price
1.05 USD -0.01 USD (-0.94%)
Last closed 1.07 USD
ISIN US95075A1079
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 48 014 756 USD
Yield for 12 month -51.83 %
1Y
3Y
5Y
10Y
15Y
HOWL
21.11.2021 - 28.11.2021

Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts. Address: 200 Talcott Ave, Watertown, MA, United States, 02472

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9.50 USD

P/E Ratio

Dividend Yield

Financials HOWL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures HOWL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+1 885 000 USD

Last Year

+19 943 000 USD

Current Quarter

Last Quarter

Current Year

+71 000 USD

Last Year

-18 963 000 USD

Current Quarter

Last Quarter

EBITDA -72 647 000 USD
Operating Margin TTM -6 511.20 %
Price to Earnings
Return On Assets TTM -32.66 %
PEG Ratio
Return On Equity TTM -82.81 %
Wall Street Target Price 9.50 USD
Revenue TTM 1 143 000 USD
Book Value 1.28 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100.00 %
Dividend Yield
Gross Profit TTM -52 244 000 USD
Earnings per share -1.64 USD
Diluted Eps TTM -1.64 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation HOWL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.67
Price Sales TTM 42.01
Enterprise Value EBITDA 0.57
Price Book MRQ 0.84

Technical Indicators HOWL

For 52 Weeks

0.60 USD 4.18 USD
50 Day MA 1.11 USD
Shares Short Prior Month 2 073 640
200 Day MA 1.50 USD
Short Ratio 2.57
Shares Short 1 835 810
Short Percent 5.79 %